Commentary: A GSH/CB dual-controlled self-assembled nanomedicine for high-efficacy doxorubicin-resistant breast cancer therapy

Overview of attention for article published in Frontiers in Pharmacology, November 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 4 Mendeley

So far, Altmetric has seen 1 X post from an account with 5,739 followers.

New Research: Commentary: A GSH/CB dual-controlled self-assembled nanomedicine for high-efficacy doxorubicin-resistant breast cancer therapy https://t.co/HbGM8Sru9W #pharmacology

28 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.